These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11120014)
61. Application of corbrin capsule in human renal transplantation. Min Z; Oi J; Zhu Y; Wei W Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813 [No Abstract] [Full Text] [Related]
63. Primary immunosuppression with tacrolimus in renal transplantation: a single center experience. Kim HC; Park SB; Han SY; Whang EA; Jeon DS; Kim HT; Cho WH; Park CH Transplant Proc; 2003 Feb; 35(1):217-8. PubMed ID: 12591370 [No Abstract] [Full Text] [Related]
64. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. Forsythe J Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049 [No Abstract] [Full Text] [Related]
65. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis. Cubas A; Herrero JC; Morales E; Carreño A; Dominguez-Gil B; Cirujeda A; Praga M; Ortuño T; Hernandez E; Delgado M; Andres A; Morales JM Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570 [No Abstract] [Full Text] [Related]
66. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group. Mycophenolate Mofetil Acute Renal Rejection Study Group Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408 [TBL] [Abstract][Full Text] [Related]
67. Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR. Cheng IK; Chan DT; Lok AS Transplant Proc; 1993 Feb; 25(1 Pt 2):1460-2. PubMed ID: 7680161 [No Abstract] [Full Text] [Related]
68. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781 [TBL] [Abstract][Full Text] [Related]
69. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G; Walsh G; Deshpande P; Koffman G Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [TBL] [Abstract][Full Text] [Related]
70. Natural history of hepatitis B and C in renal allograft recipients. Aroldi A; Lampertico P; Montagnino G; Passerini P; Villa M; Campise MR; Lunghi G; Tarantino A; Cesana BM; Messa P; Ponticelli C Transplantation; 2005 May; 79(9):1132-6. PubMed ID: 15880056 [TBL] [Abstract][Full Text] [Related]
71. Accelerated acute rejection in renal allograft. Han DJ; Yoon HS; Lee HM Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738 [No Abstract] [Full Text] [Related]
75. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection. Behrend M; Lueck R; Pichlmayr R Transplant Proc; 1997 Nov; 29(7):2927-9. PubMed ID: 9365617 [No Abstract] [Full Text] [Related]
76. Hepatitis C following renal transplantation: histopathological correlations. Hestin D; Hussenet F; Hubert J; Renoult E; Frimat L; Jacob C; Le Faou A; Kessler M Transplant Proc; 1995 Aug; 27(4):2468-9. PubMed ID: 7544506 [No Abstract] [Full Text] [Related]
77. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses. Remport A; Sasvári I; Toronyi E; Borka P; Lázár N; Járay J; Perner F Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537 [No Abstract] [Full Text] [Related]
78. Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine. Fleck PR; Schroeder TJ; Dauod AJ; Peddi VR; First MR Transplant Proc; 1998 Dec; 30(8):4070-2. PubMed ID: 9865299 [No Abstract] [Full Text] [Related]
79. Characteristics of Recipients With 10 or More Years of Allograft Survival in Deceased Donor Kidney Transplantation. Kang SS; Park WY; Jin K; Park SB; Han S Transplant Proc; 2018 May; 50(4):1013-1017. PubMed ID: 29731058 [TBL] [Abstract][Full Text] [Related]
80. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients. Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]